IsoRay’s GammaTile Cleared for Treating Recurrent Brain Neoplasms

IsoRay it received 510(k) clearance for its GammaTile therapy, a device that treats recurrent brain tumors.

The device uses proprietary Cesium-131 seeds within customizable collagen-based carriers to treat the tumors, delivering a fast-acting therapeutic dose near the tumor bed.

The seeds deliver a dose of intense radiation treatment to tissue while limiting exposure to radiation.